These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35712498)

  • 1. Associations Between Serum Reproductive Hormone Concentrations and Hormonal Receptor Status Among Postmenopausal Chinese Women With Breast Cancer: An Observational Study.
    Jiang C; Wu P; He X; Ni J; Ding X; Xu X; Wang F; Zou D
    Front Oncol; 2022; 12():819756. PubMed ID: 35712498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary, Gonadal, Thyroid Hormones and Endocrine Disruptors in Pre and Postmenopausal Nigerian Women with ER-, PR- and HER-2-Positive and Negative Breast Cancers.
    Ajayi O; Charles-Davies M; Anetor J; Ademola A
    Med Sci (Basel); 2018 May; 6(2):. PubMed ID: 29783652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma.
    Vincze B; Kapuvári B; Udvarhelyi N; Horváth Z; Mátrai Z; Czeyda-Pommersheim F; Kőhalmy K; Kovács J; Boldizsár M; Láng I; Kásler M
    Springerplus; 2015; 4():387. PubMed ID: 26240785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence and role of progesterone receptor in the ovaries of postmenopausal women who have not applied hormone replacement therapy.
    Starczewski A; Brodowska A; Laszczyńska M; Piasecka M
    Folia Histochem Cytobiol; 2008; 46(3):277-82. PubMed ID: 19056530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal profiles and estrogen receptors in Egyptian female breast cancer patients.
    Abu-Bedair FA; El-Gamal BA; Ibrahim NA; El-Aaser AA
    Tumori; 2000; 86(1):24-9. PubMed ID: 10778762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms.
    Liu J; Chen G; Meng XY; Liu ZH; Dong S
    Pathol Res Pract; 2014 Dec; 210(12):830-5. PubMed ID: 25305147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of steroid receptors in ovaries of postmenopausal women--effects of aging and hormone status.
    Brodowska A; Laszczyńska M; Starczewski A; Brodowski J; Masiuk M; Domagala W
    Histol Histopathol; 2010 Aug; 25(8):1009-16. PubMed ID: 20552551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
    Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
    Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
    Zaineddin AK; Vrieling A; Buck K; Becker S; Linseisen J; Flesch-Janys D; Kaaks R; Chang-Claude J
    Int J Cancer; 2012 Mar; 130(6):1401-10. PubMed ID: 21544804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SERUM THYROTROPIN CONCENTRATIONS ARE NOT PREDICTIVE OF AGGRESSIVE BREAST CANCER BIOLOGY IN EUTHYROID INDIVIDUALS.
    Villa NM; Li N; Yeh MW; Hurvitz SA; Dawson NA; Leung AM
    Endocr Pract; 2015 Sep; 21(9):1040-5. PubMed ID: 26121443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
    Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
    Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sex hormone levels and hormone receptor status in identifying breast cancer risk in women.
    M Akalanka KH; Ekanayake S; Samarasinghe K
    Indian J Cancer; 2021; 58(4):525-531. PubMed ID: 33402585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of serum levels of estrogen and dehydroepiandrosterone sulfate to hormone receptor status among postmenopausal women with breast cancer.
    Kakugawa Y; Minami Y; Tateno H; Inoue H; Fujiya T
    Breast Cancer; 2007; 14(3):269-76. PubMed ID: 17690503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.
    Falk RT; Gentzschein E; Stanczyk FZ; Garcia-Closas M; Figueroa JD; Ioffe OB; Lissowska J; Brinton LA; Sherman ME
    Breast Cancer Res Treat; 2012 Jan; 131(1):287-94. PubMed ID: 21870130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of reproductive history with breast tissue characteristics and receptor status in the normal breast.
    Gabrielson M; Chiesa F; Behmer C; Rönnow K; Czene K; Hall P
    Breast Cancer Res Treat; 2018 Aug; 170(3):487-497. PubMed ID: 29603032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of established risk factors with breast cancer subtypes.
    McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
    Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
    Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
    Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.